Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06640491
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-10
Brief Title:
Intraosseous IO Cefazolin and Vancomycin in Primary Total Knee Arthroplasty TKA
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Intraosseous Vancomycin and Cefazolin vs Intravenous Administration in Primary Total Knee Arthroplasty
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the efficacy of intravenous IV and intraosseous IO antibiotic administration techniques during primary total knee arthroplasty TKA in adults undergoing a TKA procedure at Houston Methodist Hospital The main questions it aims to answer are
Does IO administration of vancomycin and cefazolin protect against perioperative exposure risks Is there a difference in post-operative complication rates between IV and IO administration of these drugs
Participants will be randomized to receive either the standard of care IV administration of Vancomycin and Cefazolin or the IO administration of Vancomycin and Cefazolin
Does IO administration of vancomycin and cefazolin protect against perioperative exposure risks Is there a difference in post-operative complication rates between IV and IO administration of these drugs
Participants will be randomized to receive either the standard of care IV administration of Vancomycin and Cefazolin or the IO administration of Vancomycin and Cefazolin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None